Your browser doesn't support javascript.
loading
Palpable Nodules After Autologous Fat Grafting in Breast Cancer Patients: Incidence and Impact on Follow-up.
Dile, Pauline; Hannebicque, Karine; Renaudeau, Céline; Bogart, Émilie; Ceugnart, Luc; Regis, Claudia; Boulanger, Loïc; Chauvet, Marie-Pierre.
Afiliação
  • Dile P; Department of Obstetrics, Jeanne de Flandre University Hospital, Avenue Eugène Avinée, 59000, Lille, France. dile.pauline@hotmail.fr.
  • Hannebicque K; Department of Surgery, Centre Oscar Lambret, Lille, France.
  • Renaudeau C; Department of Surgery, Institut de cancérologie de l'Ouest, Saint Herblain, France.
  • Bogart É; Biostatistics Unit, Centre Oscar Lambret, Lille, France.
  • Ceugnart L; Department of imaging, Centre Oscar Lambret, Lille, France.
  • Regis C; Department of Surgery, Centre Oscar Lambret, Lille, France.
  • Boulanger L; Department of Surgery, Centre Oscar Lambret, Lille, France.
  • Chauvet MP; Department of Surgery, Centre Oscar Lambret, Lille, France.
Aesthetic Plast Surg ; 47(2): 503-511, 2023 04.
Article em En | MEDLINE | ID: mdl-34435220
ABSTRACT

INTRODUCTION:

Autologous fat grafting (AFG) is a promising breast reconstruction technique, following surgery. However, fat necrosis after AFG can cause palpable nodules, inducing anxiety and prompting additional investigations. We aimed to determine the occurrence rate and to identify the risk factors of palpable nodules in breast cancer patients prompting complementary explorations. MATERIALS AND

METHODS:

We retrospectively reviewed the computerized files of consecutive breast cancer patients who underwent AFG after mastectomy or breast conservative treatment (BCT) at our center from January 2013 to December 2016. We collected data regarding palpable nodule incidences and suspicious breast imaging findings that led to additional explorations.

RESULTS:

Of the 252 patients reviewed, 222 (88%) underwent AFG for breast reconstruction, while 30 (12%) underwent AFG for correction of defects after BCT. The follow-up period ranged from 0 to 74 months (median 27 months), and 201 patients had follow-ups beyond 1 year. Of the 252 patients, 66 (26.2%) underwent at least one control imaging and 24 (10%) underwent a biopsy, including 6 (2.4%) locoregional recurrence. Sixty patients (24%) were diagnosed with nodules during follow-ups. Among them, 52 (87%) patients had additional imaging, and 17 patients (28%) had a biopsy, including 82% benign histology. Patients with BCT had significantly more palpable nodules at 1 year than patients who underwent total mastectomy (odds ratio = 2.50, 95% confidence interval 1.04. 6.03, p = 0.04).

CONCLUSION:

This study underlines the importance of preoperative patient information. This intervention and its follow-up should be reserved for experienced teams to limit unnecessary additional explorations. LEVEL OF EVIDENCE IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mamoplastia Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Aesthetic Plast Surg Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mamoplastia Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Aesthetic Plast Surg Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França